不同血管通路对维持性血液透析尿毒症患者的影响

Effects of different vascular pathways in uremia patients undergoing maintenance hemodialysis

  • 摘要: 目的 探讨不同血管通路对维持性血液透析(MHD)尿毒症患者的影响。 方法 回顾性分析采用MHD治疗的154例尿毒症患者的临床资料,根据血管通路不同分为动静脉内瘘(AVF)组(n=80)和中心静脉导管(CVC)组(n=74)。比较2组透析充分性情况、营养及贫血相关指标、血液净化指标、炎症指标、并发症发生率和左心室功能。 结果 透析6个月后, 2组尿素氮(BUN)、炎症指标、半胱氨酸(Hcy)、甲状旁腺素(PTH)、β2-微球蛋白(β2-MG)水平均低于透析前,差异有统计学意义(P<0.05); AVF组BUN、炎症指标降低幅度大于CVC组,尿素清除指数(Kt/V)、血管通路栓塞、感染发生率高于CVC组,差异均有统计学意义(P<0.05); AVF组透析后血浆白蛋白(ALB)和血红蛋白(Hb)水平均高于透析前和CVC组,差异均有统计学意义(P<0.05); AVF组左心室收缩功能障碍发生率高于CVC组,差异有统计学意义(P<0.05)。 结论 AVF行MHD可改善尿毒症患者透析充分性、贫血和微炎症状态,但会增高左心室收缩功能障碍的发生风险。

     

    Abstract: Objective To explore the effects of different vascular pathways in uremia patients with maintenance hemodialysis(MHD). Methods The clinical data of 154 uremia patients who underwent MHD was retrospectively analyzed. According to different vascular pathway methods, the patients were divided into arteriovenous fistula(AVF)group(n=80)and central venous catheter(CVC)group(n=74). The dialysis adequacy conditions, related indicators of nutrition and anemia, blood purification indexes, inflammatory markers, incidence rate of complications and left ventricular function were compared between the two groups. Results After 6 months of dialysis, the levels of blood urea nitrogen(BUN), inflammatory indicators, cysteine(Hcy), parathyroid hormone(PTH), 2-microglobulin(2-MG)levels in the two groups were significantly lower than those before dialysis(P<0.05); the decreases of BUN and inflammatory markers in the AVF group were significantly greater than those in CVC group, the urea clearance index(Kt/V), incidence rates of vascular pathway embolism and infection in the AVF group were significantly higher than those in CVC group(P<0.05). The levels of plasma albumin(ALB)and hemoglobin(Hb)in the AVF group were higher than those before dialysis and the CVC group(P<0.05). The incidence rate of left ventricular systolic dysfunction in the AVF group was significantly higher than that in CVC group(P<0.05). Conclusion MHD through AVF can improve dialysis adequacy, anemia and microinflammation status in patients with uremia, but will increase the risk of left ventricular systolic dysfunction.

     

/

返回文章
返回